YORK, Pa., Aug. 30, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the development of a unique proprietary range of auto-injectors for ...

AUVI-Q (epinephrine) 0.15mg and 0.3mg auto-injector pack Sanofi announced that the FDA has approved Auvi-Q (epinephrine injection) for the emergency treatment of life-threatening allergic reactions in ...

AUVI-Q (epinephrine) 0.15mg and 0.3mg auto-injector pack Sanofi announced that Auvi-Q (epinephrine injection) is now available. Auvi-Q’s audio and visual cues include a five-second injection countdown ...

PARIS, Aug. 13, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Auvi-Q (epinephrine injection, USP) for the ...

Please provide your email address to receive an email when new articles are posted on . The epinephrine auto-injector AUVI-Q, used for the emergency treatment of anaphylaxis, will be available ...